Histopathological basis of COVID-19: A short review by Adhya, Shouvanik
Indian Journal of Biochemistry & Biophysics 
Vol. 57, December 2020, pp. 676-680 
A Review 
Histopathological basis of COVID-19: A short review 
Shouvanik Adhya* 
Department of Forensic Medicine and Toxicology, College of Medicine and JNM Hospital,  
The West Bengal University of Health Sciences, Kalyani, Nadia-741 235, West Bengal, India 
Received 16 August 2020; revised 25 September 2020 
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the global pandemic in 2020 resulting a 
massive morbidity & mortality. The lung is the predominant organ involved in symptomatic patients with Coronavirus 
disease-2019 (COVID-19) along with involvement of other organs. Understanding the histopathological changes of lung and 
other organs in COVID-19 become essential for not only formulating future management protocols but also for determing 
prognosis. The collection of potentially contaminated tissues during the autopsy and further processing of them in 
histopathology laboratory with proper maintenance of safety protocol is of immense importance. A review of the available 
scientific articles shows the diffuse alveolar damage and microvascular thrombi are common observation found in lung 
tissue in patients who died due to COVID-19. 
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Introduction 
In the late December 2019, a few cases of pneumonia 
were reported which was later linked to Huanan 
Seafood Market of Wuhan, China; subsequently, 
those are confirmed by Chinese health authorities 
that the cause of pneumonia was due to a novel 
coronavirus, later termed as Severe Acute Respiratory 
Syndrome Corona Virus 2 (SARS-CoV-2)
1
. Italy was 
the first European country to document a huge 
number of cases. Now, this SARS-CoV-2 pandemic 
has spread to almost globally affecting millions of 
people. 
The pathogenesis of SARS-CoV-2 commences 
with virus-host cell interaction by binding of spike 
envelope protein to angiotensin-converting enzyme2 
(ACE2) receptor, richly expressed on the epithelial 





This is followed by an 
exaggerated inflammatory response due to liberation 
of profuse quantity of pro-inflammatory cytokines by 
activated cytotoxic T-cells ultimately causing 
interstitial inflammation, exudates and severe 
pneumonitis in lung and also endothelial damage, 





Lung is the predominantly involved 
organ, and the common manifestation is acute 
respiratory distress syndrome. With the progression of 
the pandemic, the involvement of other organs has 
been demonstrated. In this review, the understanding 
the pathological changes in lung and other organs 
from the various studies reported in the literature was 
discussed. 
Review of Literature 
The most common reported histopathological 
findings in the lung of patients infected with SARS-
CoV-2 are as follows
4,5
. interstitial inflammation, 
necrotizing bronchitis or bronchiolitis; early diffuse 
alveolar damage characterized by intra alveolar 
edema and fibrin deposition with hyaline membrane 
formation; interstitial pneumonia manifested by 
leucocyte infiltration in alveolar septa; cytolysis and 
presence of a moderate number of multinucleated 
giant cells with the absence of any inclusion bodies
4.5
. 
These findings were not very much dissimilar from 
lung pathology in case of other viral infection
6
. 
A similar feature has been observed in a case report
7
. 
A Chinese study of the limited post-mortem 
examination
 
found desquamation of type II alveolar 
lining cells and hyaline thrombi in small vessels 
5 
in 





advanced case, the presence of fibrinoid necrosis of 
small vessels of lungs along with the hyperplasia 
of type II pneumocytes, and all components of 
diffuse alveolar damage were observed
8









small lymphocyte infiltration in hepatic lobules and 
centrilobular sinusoidal dilation along with the patchy 
necrosis were found
8
. Mild myocardial hypertrophy 
with focal fibrosis was also observed; those changes 





A study at Oklahoma, USA observed patchy hyaline 
membranes and thrombi in a few small branches of 
pulmonary arteries
9
. Histological examination of kidneys 
showed fibrin thrombi which is consistent with 
disseminated intravascular coagulation (DIC) 
10
. In a 
study in Basel, superimposed bronchopneumonia, 
pulmonary emboli, and evidence of vasculitis were  
found in addition to other common findings
11
.  
One histopathological examination of the heart  
after autopsy from COVID-19 infected patients  
showed scattered individual myocyte necrosis without 
significant lymphocyte infiltration which is typical  
of viral myocarditis
11
. In that study, it was also  
observed pulmonary megakaryocytes, with nuclear 
hyperchromasia and atypia within alveolar capillaries 
apart from the common finding of diffuse alveolar 
damage and thrombi in microvasculature
11
. 
The complement-mediated thrombotic microangiopathy 
in both the lung tissues (haemorrhagic pneumonitis with 
fibrin deposits in capillaries and endothelial cell 
necrosis) and in skin samples were reported
12
. Other 
studies reported diffuse alveolar damage with 
perivascular T-cell infiltration along with the severe 
endothelial injury and alveolar-capillary microthrombi 




Endothelitis and accumulation of inflammatory cells 
in several organs such as lung, heart, kidney, liver, and 
small intestine were observed
15
. Autopsy of COVID-19 
patients who suffered from acute kidney injury showed 
stagnation of red cells in glomerular and peritubular 
capillary lumen along with endothelitis and fibrin 
thrombi
16
. In a study from Italy, noticeable derangement 
of intra-hepatic vasculature is found, characterised by an 
increase in a number of branches in the portal vein along 
with the lumen dilatation, and/or thrombosis of the 
portal and sinusoidal vasculature, and portal tract 
fibrosis
17
. Other studies found acute tubular necrosis as 
the most common observation in kidneys; other  
varieties of observations were myoglobin casts, 
thrombotic microangiopathy, crescentic glomerulonprhites, 
glomerulosclerosis, collapsing glomerulopathy, 
membranous glomerulopathy
18,19
. The presence of 




The presence of diffuse alveolar damage  
was documented in most of the cases, but endothelitis 
was found in very few cases
21
. As in previously 
mentioned
4,5,8
, thickened alveolar septa with 
inflammatory infiltrate (mostly lymphocytes and 
macrophages), fibroblasts, and type II hyperplastic 
pneumocytes were also observed in a case report
22
. 
Another study from Italy found features of the 
exudative and proliferative phases of diffuse alveolar 
damage, which included capillary congestion, necrosis 
of pneumocytes, type 2 pneumocyte hyperplasia in all 
subjects; hyaline membranes, interstitial and intra-
alveolar edema, squamous metaplasia with atypia, and 
platelet-fibrin thrombi in most of the subjects
23
. 
One extensive study had shown not only common 
and similar pulmonary findings (Diffuse alveolar 
damage-hyaline membranes, edema, pneumocyte 
hyperplasia; lymphocytic infiltrate, multinucleated 
giant cells and enlarged, atypical pneumocytes), but 
also relevant observation in different organs such as 
lymphocytic myocarditis, hepatic shock necrosis, 
steatosis, and acute tubular necrosis in kidney
24
. 
One systematic review observed that the 
histopathological pattern of COVID-19 related 
pneumonitis appears to include epithelial, vascular, and 
 
 
Fig. 1 — Pulmonary histological findings (A) Early-stage diffuse 
alveolar damage (DAD): hyaline membrane (H & E, × 50 
magnification) with a zoom on a giant cell (× 100 magnification); 
(B) Fibrin thrombi in a pulmonary artery (H & E, × 50 
magnification); (C) Late-stage DAD: fibroblastic proliferation  
(H & E, × 50 magnification); (D) Late-stage DAD: fibroblastic 
proliferation (Trichrome staining, × 50 magnification); (E) Acute 
pneumonia (H & E, × 50 magnification); and (F) Anti-SARS-CoV 
immunohistochemistry (IHC)-positive cells (× 200 magnification) 




fibrotic patterns of lung injury
25
. A clear timeline was 
also identified to some extent, such as epithelial changes 
in all phases, vascular changes in the early phase, and 
fibrotic changes usually about three weeks after the 
onset of initial symptoms. The non- specific epithelial 
damage and inflammatory infiltrate along with evidence 
of microvascular damage in the heart, liver, kidneys, 
gastrointestinal tract and skin were also observed
25
. 
Pulmonary histopathology with evidence of diffuse 
alveolar damage, organizing pneumonia, acute fibrinous 
and organizing pneumonia; fibrotic non-specific interstitial 
pneumonia, acute interstitial pneumonia along with 
micro thrombotic event has been substantiated by 
thorough searching of few more literatures
26-31
 across the 
globe.  
Evidence has been gathered that COVID-19 
infection can be linked with extensive vascular 
endothelial damage in lung and other organs. Viral 
presence in the endothelium leads to an inflammatory 
response and microthrombi are the outcome. Alveolar 
capillary angiogenesis is evidenced in the lung, but its 
role is not yet known. Increased evidence of thrombosis 
in intravenous cannulae, extracorporeal circuits for 
dialysis ,or membrane oxygenation indicates the effects 
of COVID-19 on the coagulation system of the body
32
.  
It is evident from a review of available literature 
across the globe that the predominant prototype of 
lung pathology in COVID-19 patients is diffuse the 
alveolar damage which can be described in three 
phases, namely the exudative phase (e.g. pneumocytes 
desquamation, hyaline membrane formation, exudates 
protein- rich or cellular, fibrinoid necrosis of 
microvasculature, alveolar hemorrhage); Organizing 
phase (e.g. interstitial and intra alveolar fibroblasts 
proliferation, type II pneumocyte hyperplasia, lymphocytic 
infiltration, fibrin deposition); Fibrotic phase (e.g. 
dense collagenous fibrosis, architectural remodeling), 




As found in one study, the pattern of lung damage 
in severe SARS-CoV-2 infection is not diffuse 
alveolar damage which was the most predominant 
observations of almost all other researchers. As per 
their finding histologic pattern was an acute fibrinous 
and organizing pneumonia (AFOP) evidenced by 
intra-alveolar fibrin deposition known as fibrin balls, 
in place of hyaline membrane formation
34
. 
Besides diffuse alveolar damage, another major 
common observation from the histopathological study 
was diffuse thrombotic vascular involvement in 
multiple organs including the lungs. This finding is 
linked with high levels of D-dimers in the blood and 
could be pertinent in targeted management of SARS-




Though the histopathology is not a part of a routine 
investigation in the case of COVID-19, pathologists 
may find suspected cases at autopsy, or in biopsy 
samples. In COVID-19 victims, predominant 
histopathological observations are diffuse alveolar 
damage in lung and multiorgan microvascular 
thrombi. Hence finding a link between the signs and 
symptoms and pathological (both macroscopic and 
microscopic) evidence are not only significant for 
autopsy pathologist, but also for identifying the better 
therapeutic approaches to reduce the morbidity and 
mortality due to COVID-19.  
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